By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic biomarker-based tests designed to predict individual risk for Alzheimer's disease may be valuable in research projects and potential treatments, but they are not ready to provide valuable information for use in predicting disease risk in the clinic, according to a new set of Alzheimer's diagnostic guidelines issued Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.